Neeraj Roshanial Sharma, MD
Internal Medicine, Medical Oncology (MD) with Texas Oncology PA, practicing in Longview, Texas. Their prescriptions cost Medicare Part D more than their services did: $5,298,196 for 2,202 claims, against $2,127,408 paid for services in 2024. Incyte Corporation was the largest of 20 companies reporting payments in 2025, $1,802 in all, mostly food and beverage. Lists Christus Good Shepherd Medical Center and 2 other hospitals as hospital affiliations.
Overview
| NPI | 1851334759 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 14, 2006 |
| Last updated in NPPES | May 8, 2008 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | L1459 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 907 |
|---|---|
| Services billed | 153,540 across 185 procedure codes |
| Paid by Medicare | $2,127,408 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,202 · 2,980 30-day fills |
|---|---|
| Patients | 328 |
| Total drug cost | $5,298,196 |
| Generic share | 75% of claims |
Education and affiliations
| Graduation year | 1991 |
|---|---|
| Medicare specialty | Medical Oncology |
| Secondary specialties | Internal Medicine |
Medical group
- Texas Oncology PAPlano, TX · 1,014 clinicians
Hospital affiliations
- Christus Good Shepherd Medical CenterLongview, TX
- Ennis Regional Medical CenterEnnis, TX
- Longview Regional Medical CenterLongview, TX
Industry payments (Open Payments)
- 2025$1,802 · 48 payments from 20 companies
- 2024$2,037 · 37 payments from 17 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Incyte Corporation | $943.38 | 6 |
| Pfizer Inc. | $110.55 | 5 |
| Astrazeneca Pharmaceuticals LP | $105.14 | 5 |
| Regeneron Healthcare Solutions, Inc. | $79.75 | 4 |
| Merck Sharp & Dohme LLC | $67.08 | 3 |
What the 2025 payments were for
- Food and Beverage$941.96 · 47 payments
- Consulting Fee$860.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in Longview
- 1821031253
- 1942242995
- 1295050037
- 1629269774
All Internal Medicine, Medical Oncology providers in Texas →